MedicBK automatically determines patients' most significant risk factors, their absolute and relative contraindications. It provides treatment options based on current clinical practise guidelines (ESC & AHA for cardiology, NCCN for oncology).
The program uses a digital patient model to calculate efficiency and safety of available drugs and interventions in comparison with each other and upon a patient's health profile (by network-meta-analysis).
The digital model is built on databases from multi-centre randomised controlled trials.